Skip to content

    Cytosorbents (CTSO) stock price & financials

    View CTSO earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance63.4% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $8.61M
    $9.15M
    $8.73M
    $9.62M
    $9.48M
    +10.1%
    $9.23M
    +0.9%
    $8.86M
    +1.6%
    $9.63M
    +0.2%
    Stable
    Operating Profit
    -$4.83M
    -$3.40M
    -$3.89M
    -$3.62M
    -$2.86M
    +40.7%
    -$4.38M
    -29.1%
    -$3.04M
    +21.7%
    -$2.64M
    +27.0%
    Strengthening
    Net Profit
    -$2.77M
    -$7.57M
    -$1.48M
    $1.95M
    -$3.17M
    -14.5%
    -$5.50M
    +27.4%
    -$5.13M
    -246.8%
    -$4.42M
    -326.9%
    Weakening
    EPS
    $-0.05
    $-0.02
    $0.03
    $-0.05
    +0.0%
    $-0.08
    -300.0%
    $-0.07
    -333.3%
    Weakening
    Other Income
    $2.06M
    -$5.86M
    $2.41M
    $5.56M
    -$709.0K
    -134.4%
    -$1.11M
    +81.0%
    -$2.08M
    -186.6%
    -$1.78M
    -132.0%
    Weakening
    Interest
    Depreciation
    Profit before Tax
    -$2.77M
    -$9.41M
    -$1.48M
    -$3.57M
    -29.0%
    MarginsOPM
    -56.1%
    -37.1%
    -44.5%
    -37.6%
    -30.2%
    +46.2%
    -47.5%
    -27.9%
    -34.3%
    +22.9%
    -27.4%
    +27.1%
    Strengthening
    Tax
    0.0%
    0.0%
    11.2%
    ReturnsROIC
    0.9%
    2.4%
    0.5%
    -0.6%
    1.0%
    +14.5%
    1.7%
    -27.4%
    1.6%
    +246.8%
    1.4%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$22.37M$12.23M$71.42M$52.14M$22.14M$14.13M$3.28M$6.25M$4.41M
    Short-Term Investments
    Total Current Assets$28.26M$20.90M$82.45M$64.30M$33.76M$25.40M$21.60M$20.63M$15.74M
    Net PP&E$3.18M$3.00M$3.15M$18.57M$23.35M$22.12M$20.51M$18.75M$17.78M
    Goodwill
    Intangibles$2.63M$3.36M$4.22M$4.70M$4.39M$3.91M$3.72M$3.23M$2.86M
    Total Assets$34.20M$27.38M$89.95M$89.52M$63.23M$52.96M$47.37M$44.18M$37.96M
    LiabilitiesTotal Current Liabilities$6.92M$9.94M$10.15M$13.69M$9.71M$14.04M$9.82M$9.71M$24.02M
    Short-Term Debt$666.7K$1.67M$0$2.50M$14.15M
    Long-Term Debt$9.27M$13.39M$0$5.00M$2.54M$14.00M$16.67M$3.09M
    Long-Term Leases$1.07M$642.7K$581.6K$13.25M$13.14M$12.90M$12.44M$11.90M$11.60M
    Total Liabilities$17.26M$23.96M$10.73M$26.94M$27.86M$29.48M$36.27M$38.28M$38.71M
    EquityCommon Stock & APIC$31.8K$32.6K$43.2K$43.5K$43.6K$54.2K$55.0K$63.0K$63.0K
    Retained Earnings-$169.52M-$188.79M-$196.63M-$221.19M-$254.00M-$283.29M-$304.01M-$312.21M-$321.75M
    Total Equity$16.93M$3.42M$79.22M$62.58M$35.37M$23.48M$11.11M$5.90M-$751.0K
    HighlightsNet Cash / (Debt)$12.43M-$2.82M$71.42M$9.09M-$12.83M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$10.84M-$16.76M-$5.61M-$14.01M-$28.23M-$21.66M-$14.43M-$12.38M-$9.15M
    Cash from Investing-$1.52M-$1.52M-$1.68M-$4.28M-$6.46M-$936.2K-$669.0K-$415.0K-$275.0K
    Cash from Financing$17.47M$8.18M$66.35M$715.2K$4.96M$14.47M$9.33M$9.31M
    SummaryCapital Expenditure-$672.0K-$698.2K-$708.4K-$3.64M-$6.09M-$538.1K-$284.0K-$164.0K-$150.0K
    Free Cash Flow-$11.51M-$17.46M-$6.32M-$17.65M-$34.32M-$22.19M-$14.71M-$12.54M-$9.30M
    FCF Margin-51.2%-70.0%-15.4%-40.9%-98.9%-71.4%-41.3%-33.8%-25.0%

    Ratios